Results 261 to 270 of about 37,425 (325)
Advances in the Development of Lipid Nanoparticles for mRNA Delivery
This review provides an integrated overview of mRNA–lipid nanoparticle (LNP) design, including lipid composition, scalable manufacturing, and structure–activity relationships. We highlight strategies for targeted delivery, physicochemical tuning, and high‐throughput screening such as DNA barcoding.
Xing Wang +6 more
wiley +1 more source
Bacterial contaminants in occupational environments may elicit an immune response. This study investigated the immune‐modulatory potential of bacterial communities using in vitro cell‐based assays and revealed distinctive bacterial species as drivers of TLR2 and TLR4 activation. The presented approach studied the role of bacterial species as modulators
Elke Eriksen +2 more
wiley +1 more source
Multifunctional Engineering of Exosomes for Precision Therapeutics: Strategies for Targeted Delivery, Barrier Evasion, and Clinical Translation. [PDF]
Mendonca SR +4 more
europepmc +1 more source
Synaptic vesicle glycoprotein 2A, the newly identified APP‐binding protein, reduces amyloid‐β plaque deposition in Alzheimer's disease by suppressing the amyloidogenic pathway through inhibition of BACE1‐APP interaction and alteration of APP endosomal‐lysosomal localization.
Xiaoling Wang +11 more
wiley +1 more source
ESCRTing the RABs through conversion. [PDF]
Solinger JA, Ott DP, Spang A.
europepmc +1 more source
Research Progress of Exosome‐Derived microRNA in Alcohol Use Disorders: A Critical Review
Exosome‐derived microRNAs represent stable and mechanistically active mediators of alcohol‐induced multi‐organ injury. This review summarizes how chronic alcohol exposure reshapes exosomal miRNA cargo across the liver, immune system, and brain, highlighting key miRNAs with diagnostic value and therapeutic potential.
Bo Zhang +4 more
wiley +1 more source
Redefining the Limits of Nanodevices-Based Drug Delivery Systems: Extracellular Vesicles. [PDF]
Díaz ML +3 more
europepmc +1 more source
Non‐coding RNAs (ncRNAs) regulate breast cancer radioresistance via cell cycle, DNA repair and tumour microenvironment pathways. Targeting ncRNAs (e.g., HOTAIR and miR‐155) with RNA‐based therapies (ASOs and CRISPR) shows promise but faces delivery challenges.
Xiaohui Zhao +8 more
wiley +1 more source
Revisiting the role of Annexins in membrane trafficking. [PDF]
Grewal T +4 more
europepmc +1 more source

